Shares of Teleflex Incorporated (NYSE:TFX - Get Free Report) hit a new 52-week low during mid-day trading on Friday . The company traded as low as $171.63 and last traded at $173.45, with a volume of 57596 shares. The stock had previously closed at $173.62.
A number of equities research analysts recently issued reports on the stock. Royal Bank of Canada dropped their price target on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a research note on Friday, November 1st. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a report on Monday, December 16th. Truist Financial decreased their price objective on Teleflex from $227.00 to $200.00 and set a "hold" rating on the stock in a report on Wednesday, December 18th. StockNews.com upgraded shares of Teleflex from a "hold" rating to a "buy" rating in a research report on Thursday, November 28th. Finally, Mizuho lowered their target price on Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a report on Friday, November 1st. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Teleflex currently has a consensus rating of "Moderate Buy" and a consensus price target of $252.50.
View Our Latest Research Report on TFX
The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The firm has a market cap of $8.03 billion, a price-to-earnings ratio of 34.37, a price-to-earnings-growth ratio of 1.78 and a beta of 1.16. The firm has a 50-day moving average price of $180.48 and a two-hundred day moving average price of $211.61.
Large investors have recently bought and sold shares of the business. Simplify Asset Management Inc. acquired a new stake in shares of Teleflex in the 3rd quarter worth $4,800,000. JPMorgan Chase & Co. lifted its position in shares of Teleflex by 14.3% in the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company's stock valued at $38,374,000 after acquiring an additional 19,466 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its position in shares of Teleflex by 19.8% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 484 shares of the medical technology company's stock valued at $102,000 after buying an additional 80 shares during the last quarter. LGT Capital Partners LTD. lifted its position in Teleflex by 4.2% during the third quarter. LGT Capital Partners LTD. now owns 231,685 shares of the medical technology company's stock worth $57,300,000 after buying an additional 9,411 shares during the period. Finally, Allspring Global Investments Holdings LLC raised its stake in Teleflex by 41.5% during the third quarter. Allspring Global Investments Holdings LLC now owns 24,301 shares of the medical technology company's stock worth $6,010,000 after purchasing an additional 7,132 shares during the period. Institutional investors and hedge funds own 95.62% of the company's stock.
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you make your next trade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.
Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.
They believe these five stocks are the five best companies for investors to buy now...
See The Five Stocks Here
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.